Bright Financial Statements From 2010 to 2026

DRUG Stock  USD 89.41  0.74  0.83%   
Bright Minds' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bright Minds' valuation are provided below:
Market Capitalization
887.7 M
Earnings Share
(1.28)
There are over one hundred nineteen available fundamental signals for Bright Minds Biosciences, which can be analyzed over time and compared to other ratios. Active traders should verify all of Bright Minds Biosciences prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Bright Minds' current Market Cap is estimated to increase to about 548.5 M. The Bright Minds' current Enterprise Value is estimated to increase to about 470.3 M
Check Bright Minds financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bright Minds' main balance sheet or income statement drivers, such as Depreciation And Amortization of 60.3 K, Interest Expense of 49.2 K or Selling General Administrative of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.73. Bright financial statements analysis is a perfect complement when working with Bright Minds Valuation or Volatility modules.
  
Build AI portfolio with Bright Stock
Check out the analysis of Bright Minds Correlation against competitors.

Bright Minds Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets101.9 M97.1 M19.5 M
Slightly volatile
Other Current Liabilities579.4 K551.8 K130.6 K
Slightly volatile
Total Current Liabilities2.8 M2.7 M661.3 K
Slightly volatile
Total Stockholder Equity71.1 M67.7 M14.2 M
Slightly volatile
Net Tangible Assets8.4 M12.1 M4.9 M
Slightly volatile
Accounts Payable2.1 MM508.5 K
Slightly volatile
Cash100.1 M95.3 M19 M
Slightly volatile
Non Current Assets Total82.2 K128.8 K82.7 K
Pretty Stable
Cash And Short Term Investments100.1 M95.3 M19 M
Slightly volatile
Common Stock Shares Outstanding8.3 M7.9 M2.8 M
Slightly volatile
Liabilities And Stockholders Equity73.2 M69.7 M14.8 M
Slightly volatile
Total Liabilities2.9 M2.7 M676.1 K
Slightly volatile
Total Current Assets101.8 M97 M19.4 M
Slightly volatile
Intangible Assets1.711.81.1 K
Slightly volatile
Common Stock106.9 M101.8 M25.2 M
Slightly volatile
Good Will1.6 K1.8 KK
Slightly volatile
Other Current Assets1.2 M1.1 M275.1 K
Slightly volatile
Net Invested Capital99.1 M94.4 M19.1 M
Slightly volatile
Capital Stock148.8 M141.7 M32.5 M
Slightly volatile
Net Working Capital99 M94.3 M19.1 M
Slightly volatile
Net Receivables498.8 K475 K167.1 K
Slightly volatile
Short Term Investments64.1 K55.7 K80.3 K
Slightly volatile
Short and Long Term Debt Total126 K144.6 K133.4 K
Slightly volatile
Short Term Debt100.7 K167 K81.2 K
Slightly volatile
Property Plant Equipment111.1 K125 K136.4 K
Slightly volatile

Bright Minds Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization60.3 K63.5 K294.6 K
Pretty Stable
Selling General Administrative1.5 M2.5 M826.9 K
Slightly volatile
Selling And Marketing Expenses320.7 K494.1 K185.2 K
Slightly volatile
Other Operating Expenses16.8 M16 M4.9 M
Slightly volatile
Research Development5.2 M9.2 M2.9 M
Slightly volatile
Total Operating Expenses6.9 M11.4 M3.8 M
Slightly volatile
Cost Of Revenue49 K63.5 K21.6 K
Slightly volatile

Bright Minds Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation92.8 K88.4 K28 K
Slightly volatile
Total Cash From Financing Activities74.2 M70.7 M14.3 M
Slightly volatile
End Period Cash Flow71.8 M68.4 M14.4 M
Slightly volatile
Change To Netincome548.8 K744.8 K383.7 K
Slightly volatile
Change To Liabilities924.9 K880.9 K380.9 K
Slightly volatile
Stock Based Compensation3.8 M3.7 M943.9 K
Slightly volatile
Begin Period Cash Flow7.9 M4.8 M3.3 M
Slightly volatile
Issuance Of Capital Stock99.1 M94.4 M18.8 M
Slightly volatile
Change To Inventory62.3 K41.1 K88.1 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio7.738.14234
Slightly volatile
Book Value Per Share11.2710.743.1493
Slightly volatile
Average Payables403.7 K265.4 K276 K
Slightly volatile
Capex To Depreciation1.0E-41.0E-41.0E-4
Slightly volatile
PB Ratio7.738.14234
Slightly volatile
Payables Turnover0.04910.05170.046
Slightly volatile
Cash Per Share11.410.863.1983
Slightly volatile
Days Payables Outstanding8.9 K9.3 K54.9 K
Slightly volatile
Income Quality0.590.640.6301
Slightly volatile
Intangibles To Total Assets1.0E-41.0E-40.0066
Slightly volatile
Net Debt To EBITDA6.466.151.8694
Slightly volatile
Current Ratio34.1232.4911.954
Slightly volatile
Tangible Book Value Per Share11.2710.743.1483
Slightly volatile
Shareholders Equity Per Share11.2710.743.1493
Slightly volatile
Debt To Equity0.00170.00180.0116
Slightly volatile
Capex Per Share0.00.00.0
Slightly volatile
Graham Net Net11.1210.593.0627
Slightly volatile
Average Receivables108.9 K208.5 K131.3 K
Very volatile
Interest Debt Per Share0.02570.0270.1113
Slightly volatile
Debt To Assets0.00160.00170.0102
Slightly volatile
Price Book Value Ratio7.738.14234
Slightly volatile
Days Of Payables Outstanding8.9 K9.3 K54.9 K
Slightly volatile
Ebt Per Ebit1.091.011.0
Very volatile
Company Equity Multiplier1.231.181.2098
Slightly volatile
Total Debt To Capitalization0.00170.00180.0114
Slightly volatile
Debt Equity Ratio0.00170.00180.0116
Slightly volatile
Quick Ratio34.1232.4911.954
Slightly volatile
Net Income Per E B T0.80.910.9923
Slightly volatile
Cash Ratio33.5531.9511.7412
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9824
Slightly volatile
Price To Book Ratio7.738.14234
Slightly volatile
Debt Ratio0.00160.00170.0102
Slightly volatile
Price Fair Value7.738.14234
Slightly volatile

Bright Minds Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap548.5 M522.4 M136.1 M
Slightly volatile
Enterprise Value470.3 M447.9 M119.7 M
Slightly volatile

Bright Fundamental Market Drivers

Bright Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Bright Minds Financial Statements

Bright Minds stakeholders use historical fundamental indicators, such as Bright Minds' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bright Minds investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bright Minds' assets and liabilities are reflected in the revenues and expenses on Bright Minds' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bright Minds Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue63.5 K49 K

Currently Active Assets on Macroaxis

When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out the analysis of Bright Minds Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.28)
Return On Assets
(0.19)
Return On Equity
(0.28)
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.